Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Akebia Therapeutics, Inc. AKBA is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 26.3% downward over the last 60 days.
Coca-Cola FEMSA, S.A.B. de C.V. KOF is a franchise bottler company. The Zacks Consensus Estimate for its current year earnings has been revised 10.5% downward over the last 60 days.
DENTSPLY SIRONA Inc. XRAY is a dental products company.The Zacks Consensus Estimate for its current year earnings has been revised 6.5% downward over the last 60 days.
View the entire Zacks Rank #5 List.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis Report
Coca Cola Femsa S.A.B. de C.V. (KOF): Free Stock Analysis Report
Akebia Therapeutics, Inc. (AKBA): Free Stock Analysis Report
/Microsoft%20sign%20at%20the%20headquarters%20by%20VDB%20Photos%20via%20Shutterstock.jpg)
